TSVT logo

2seventy bio (TSVT)

Profile

Full Name

2seventy bio, Inc.

Ticker Symbol

TSVT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 3, 2021

Indexes

Not included

Website

http://www.2seventybio.com

Employees

65

Key Details

Price

$4.97(+0.20%)

Market cap

$260.12M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$37.86M(-62.28% YoY)

Annual EPS

-$1.10(+75.11% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.97
TSVT price is $4.97

30-Day Relative Volume

0.76
TSVT 30-day relative volume is 0.76

Price Performance

Price Today change

+0.2%
TSVT price is up +0.2% today

Price YTD change

+69.05%
TSVT price is up +69.05% since January 1st

Price 1-year change

-0.3%
TSVT price is down -0.3% year-on-year

Price 3-year change

-70.47%
TSVT price is down -70.47% over the past 3 years

Price Range

Price All-time high

$64.00
TSVT price is currently -92.23% below its historical high of $64.00

Price 3-year low

$1.53
TSVT price is currently +223.78% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$260.12M
TSVT market capitalization is $260.12 million

Market cap 3-year change

-58.91%
TSVT market capitalization is down -58.91% over the past 3 years

Market cap All-time high

$994.59M
TSVT market capitalization is currently -73.85% below its historical high of $994.59 million

Market cap sector rank

61.43%
TSVT market capitalization is higher than 61.43% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.82%
TSVT shares outstanding is up +1.82% year-on-year

Shares Outstanding 3-Year Change

+39.13%
TSVT shares outstanding is up +39.13% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.51
TSVT beta is 0.51

200-day SMA

$3.99
TSVT price is currently +24.43% above its 200-day simple moving average

50-day SMA

$3.77
TSVT price is currently +31.91% above its 50-day simple moving average

RSI

76.14
TSVT 14-day relative strength index is 76.14

Volume

0.76
TSVT 30-day relative volume is 0.76

ATR

$0.07
TSVT average true range is $0.07

10-day Historical Volatility

9.05%
TSVT 10-day historical volatility is 9.05%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$37.86M
TSVT annual revenue is $37.86 million

Revenue Analysts estimate

$68.47M
TSVT annual revenue is currently -44.70% lower than the consensus analysts' forecast

Revenue 1-year change

-62.28%
TSVT annual revenue is down -62.28% year-on-year

Revenue Sector rank

43.45%
TSVT annual revenue is higher than 43.45% of companies in Healthcare sector

EPS

EPS

-$1.10
TSVT annual earnings per share is -$1.10

EPS Analysts estimate

-$0.16
TSVT annual earnings per share is currently +587.50% higher than the consensus analysts' forecast

EPS 1-year change

+75.11%
TSVT annual earnings per share is up +75.11% year-on-year

EPS Sector rank

54.51%
TSVT annual earnings per share is higher than 54.51% of companies in Healthcare sector

Profit

Gross profit

$15.30M
TSVT annual gross profit is $15.30 million

Gross margin

40.41%
TSVT annual gross profit margin is 40.41%

Operating profit

-$105.54M
TSVT annual operating income is -$105.54 million

Operating margin

-278.75%
TSVT annual operating profit margin is -278.75%

Net income

-$57.25M
TSVT annual net profit is -$57.25 million

Net margin

-151.20%
TSVT annual net profit margin is -151.20%

Expenses

Total expenses

$143.40M
TSVT annual total expenses is $143.40 million

Operating expenses

$120.84M
TSVT annual total operating expenses is $120.84 million

Cost of goods sold

$22.56M
TSVT annual cost of goods sold is $22.56 million

Selling, general & administrative expenses

$43.92M
TSVT annual SGA is $43.92 million

Depreciation and amortization

$7.10M
TSVT annual depreciation & amortization is $7.10 million

Interest expense

-
TSVT annual interest expense value is unknown

Income tax

$0.00
TSVT annual income tax is $0.00

EBIT & EBITDA

EBIT

-$105.54M
TSVT annual earnings before interest & taxes is -$105.54 million

EBITDA

-$98.45M
TSVT annual EBITDA is -$98.45 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$479.51M
TSVT annual total assets is $479.51 million

Non current assets

$292.25M
TSVT annual long term assets is $292.25 million

Current assets

$187.26M
TSVT annual total current assets is $187.26 million

Cash and cash equivalents

$71.24M
TSVT annual cash & cash equivalents is $71.24 million

Accounts receivable

$7.78M
TSVT annual accounts receivable is $7.78 million

Inventory

-
TSVT annual inventory value is unknown

Liabilities

Total liabilities

$268.70M
TSVT annual total liabilities is $268.70 million

Long term liabilities

$228.61M
TSVT annual total long term liabilities is $228.61 million

Current liabilities

$40.09M
TSVT annual total current liabilities is $40.09 million

Accounts payable

$1.05M
TSVT annual accounts payable is $1.05 million

Debt

Total debt

$243.72M
TSVT annual total debt is $243.72 million

Total debt 1-year change

-5.05%
TSVT annual total debt is down -5.05% year-on-year

Long term debt

$227.35M
TSVT annual long term debt is $227.35 million

Short term debt

$16.36M
TSVT annual short term debt is $16.36 million

Equity & Capital

Shareholders equity

$210.81M
TSVT annual stockholders equity is $210.81 million

Book value

$210.81M
TSVT annual book value is $210.81 million

Retained earnings

-$568.46M
TSVT annual retained earnings is -$568.46 million

Working capital

$147.16M
TSVT annual working capital is $147.16 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$85.00M
TSVT annual cash flow from operations is -$85.00 million

Cash from operations 1-year change

+49.06%
TSVT annual cash flow from operations is up +49.06% year-on-year

Cash from investing

$80.76M
TSVT annual cash flow from investing activities is $80.76 million

Cash from investing 1-year change

+84.13%
TSVT annual cash flow from investing activities is up +84.13% year-on-year

Cash from financing

$417.00K
TSVT annual cash flow from financing activities is $417.00 thousand

Cash from financing 1-year change

-99.67%
TSVT annual cash flow from financing activities is down -99.67% year-on-year

CAPEX

CAPEX

$707.00K
TSVT annual capital expenditures is $707.00 thousand

CAPEX 1-year change

-94.9%
TSVT annual capital expenditures is down -94.9% year-on-year

Free Cash Flow

Free cash flow

-$85.70M
TSVT annual free cash flow is -$85.70 million

Free cash flow 1-year change

+52.58%
TSVT annual free cash flow is up +52.58% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

40.41%
TSVT annual gross profit margin is 40.41%

Operating margin

-278.75%
TSVT annual operating profit margin is -278.75%

Net margin

-151.20%
TSVT annual net profit margin is -151.20%

ROA & ROE

ROA

-10.96%
TSVT annual return on assets is -10.96%

ROE

-24.56%
TSVT annual return on equity is -24.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TSVT price to earnings ratio value is unknown

PE ratio Sector rank

-
TSVT price to earnings ratio is unknown

PB Ratio

PB ratio

1.23
TSVT price to book ratio is 1.23

PB ratio Sector rank

49.05%
TSVT price to book ratio is higher than 49.05% of companies in Healthcare sector

PS Ratio

PS ratio

6.87
TSVT price to sales ratio is 6.87

PS ratio Sector rank

73.46%
TSVT price to sales ratio is higher than 73.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$432.59M
TSVT enterprise value is $432.59 million

Enterprise value Sector rank

67.85%
TSVT enterprise value is higher than 67.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.39
TSVT EV/EBITDA is -4.39

EV/EBITDA Sector rank

20.17%
TSVT EV/EBITDA is higher than 20.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.67
TSVT annual current ratio is 4.67

Quick ratio

-
TSVT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
TSVT annual debt to equity ratio is 0.00

Interest coverage ratio

-
TSVT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
TSVT piotroski f-score is 2

Altman Z-Score

-1.36
TSVT altman z-score is -1.36

Analyst ratings

Recent major analysts updates

Mar 14, 25 Morgan Stanley
Equal-Weight
Mar 11, 25 Leerink Partners
Market Perform
Jul 29, 24 Morgan Stanley
Equal-Weight
Jun 27, 24 Wedbush
Neutral
May 9, 24 Canaccord Genuity
Buy
Apr 8, 24 Citigroup
Buy
Mar 18, 24 Wedbush
Neutral
Jan 31, 24 TD Cowen
Market Perform
Jan 31, 24 Leerink Partners
Outperform
Nov 20, 23 Wedbush
Neutral

Institutional Ownership

Similar stocks

VMD logo
Viemed Healthcare (VMD)
ZIMV logo
ZimVie (ZIMV)
TSHA logo
Taysha Gene Therapies (TSHA)
MRVI logo
Maravai LifeSciences Holdings (MRVI)
VNDA logo
Vanda Pharmaceuticals (VNDA)
CERS logo
Cerus (CERS)
SMTI logo
Sanara MedTech (SMTI)
ATYR logo
aTyr Pharma (ATYR)
AVIR logo
Atea Pharmaceuticals (AVIR)
  • What is the ticker symbol for 2seventy bio?
  • Does 2seventy bio pay dividends?
  • What sector is 2seventy bio in?
  • What industry is 2seventy bio in?
  • What country is 2seventy bio based in?
  • When did 2seventy bio go public?
  • Is 2seventy bio in the S&P 500?
  • Is 2seventy bio in the NASDAQ 100?
  • Is 2seventy bio in the Dow Jones?
  • When was 2seventy bio's last earnings report?
  • When does 2seventy bio report earnings?
  • Should I buy 2seventy bio stock now?

What is the ticker symbol for 2seventy bio?

The ticker symbol for 2seventy bio is NASDAQ:TSVT

Does 2seventy bio pay dividends?

No, 2seventy bio does not pay dividends

What sector is 2seventy bio in?

2seventy bio is in the Healthcare sector

What industry is 2seventy bio in?

2seventy bio is in the Biotechnology industry

What country is 2seventy bio based in?

2seventy bio is headquartered in United States

When did 2seventy bio go public?

2seventy bio's initial public offering (IPO) was on November 3, 2021

Is 2seventy bio in the S&P 500?

No, 2seventy bio is not included in the S&P 500 index

Is 2seventy bio in the NASDAQ 100?

No, 2seventy bio is not included in the NASDAQ 100 index

Is 2seventy bio in the Dow Jones?

No, 2seventy bio is not included in the Dow Jones index

When was 2seventy bio's last earnings report?

2seventy bio's most recent earnings report was on Mar 25, 2025

When does 2seventy bio report earnings?

The next expected earnings date for 2seventy bio is May 8, 2025

Should I buy 2seventy bio stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page